Co Diagnostics Other Current Assets Over Time
| CODX Stock | USD 0.73 0.03 3.95% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Co Diagnostics Performance and Co Diagnostics Correlation. CODX |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Co Diagnostics. If investors know CODX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Co Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.308 | Earnings Share (1.38) | Revenue Per Share 0.244 | Quarterly Revenue Growth (0.74) | Return On Assets (0.28) |
The market value of Co Diagnostics is measured differently than its book value, which is the value of CODX that is recorded on the company's balance sheet. Investors also form their own opinion of Co Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Co Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Co Diagnostics' market value can be influenced by many factors that don't directly affect Co Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Co Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Co Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Co Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Current Assets Analysis
Compare Co Diagnostics and related stocks such as Heart Test Laboratories, NanoVibronix, and Rapid Micro Biosystems Other Current Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HSCS | 52.8 K | 52.8 K | 52.8 K | 52.8 K | 52.8 K | 52.8 K | 52.8 K | 52.8 K | 52.8 K | 52.8 K | 163.8 K | 89.8 K | 359.8 K | 917.1 K | 962.9 K |
| NAOV | 5 K | 5 K | 32 K | 32 K | 19 K | 50 K | 34 K | 45 K | 42 K | 249 K | 590 K | 166 K | 612 K | 47 K | 44.6 K |
| RPID | 2 K | 2 K | 336 K | 336 K | 336 K | 336 K | 336 K | 336 K | 336 K | 336 K | 2.3 M | 3.6 M | 3.3 M | 2.8 M | 2.3 M |
| BMRA | 200 K | 387.7 K | 340.7 K | 190.6 K | 238.4 K | 113.6 K | 195.8 K | 300.4 K | 202.4 K | 1.5 M | 370.3 K | 320.7 K | 300 K | 238 K | 285.8 K |
| BJDX | 69.9 K | 69.9 K | 69.9 K | 69.9 K | 69.9 K | 69.9 K | 69.9 K | 69.9 K | 69.9 K | 69.9 K | 61.1 K | 1.6 M | 1.7 M | 1 M | 974.5 K |
| MOVE | 72.7 M | 7.1 M | 7.2 M | 8.2 M | 222 K | 222 K | 222 K | 222 K | 222 K | 222 K | 691 K | 2.8 M | 990 K | 841 K | 799 K |
| NVNO | 199.4 K | 199.4 K | 199.4 K | 199.4 K | 199.4 K | 199.4 K | 56 K | 57.5 K | 64.3 K | 116.6 K | 468.9 K | 624.4 K | 392 K | 511 K | 304.4 K |
| TIVC | 175 K | 175 K | 175 K | 175 K | 175 K | 175 K | 175 K | 175 K | 175 K | 175 K | 160 K | 793 K | 1.1 M | 327 K | 552 K |
| BBLG | 85.77 | 85.77 | 85.77 | 85.77 | 89.5 K | 86 K | 80.5 K | 105.2 K | 85.3 K | 6.7 K | 956.9 K | 956.9 K | 956.9 K | 711.2 K | 746.8 K |
| SENS | 197 K | 197 K | 197 K | 197 K | 711 K | 1 M | 365 K | 68 K | 142 K | 223 K | 4 M | 6.5 M | 7.4 M | 7.3 M | 7.6 M |
| INGN | 433 K | 433 K | 309 K | 531 K | 1.1 M | 870 K | 1.7 M | 2.6 M | 7.1 M | 10.2 M | 17.9 M | 26 M | 19.2 M | 14.5 M | 8.7 M |
| CLPT | 19.8 K | 19.8 K | 63.2 K | 174.9 K | 29.2 K | 97.2 K | 135 K | 192.7 K | 213.7 K | 357.2 K | 488 K | 1 M | 1.7 M | 1.2 M | 1.2 M |
| NPCE | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.3 M | 1.2 M | 4.5 M | 3.1 M | 2.7 M | 2.8 M |
| SRDX | 3.8 M | 31.3 M | 1.4 M | 1.1 M | 1.7 M | 1.2 M | 1.8 M | 3.6 M | 4.4 M | 5.8 M | 1.7 M | 2.6 M | 7.9 M | 2.9 M | 2.7 M |
| CVRX | 375 K | 375 K | 375 K | 375 K | 375 K | 375 K | 375 K | 375 K | 375 K | 375 K | 605 K | 5.2 M | 4.2 M | 3 M | 2.9 M |
| NURO | 140 K | 531.4 K | 1.9 M | 1.4 M | 1.9 M | 2.7 M | 3.6 M | 5.1 M | 4.9 M | 2.3 M | 478.1 K | 598.4 K | 645.5 K | 779 K | 1.5 M |
| RSLS | 141.6 K | 1 M | 771.7 K | 546.7 K | 421.7 K | 831.5 K | 3.3 M | 467.8 K | 1.3 M | 1.7 M | 1.1 M | 1.4 M | 265 K | 437 K | 415.1 K |
| IINN | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 51.0 | 45 K | 759 K | 7.7 M | 432 K | 410.4 K |
Co Diagnostics and related stocks such as Heart Test Laboratories, NanoVibronix, and Rapid Micro Biosystems Other Current Assets description
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.My Equities
My Current Equities and Potential Positions
| Co Diagnostics | CODX |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Utah; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.73
Additional Tools for CODX Stock Analysis
When running Co Diagnostics' price analysis, check to measure Co Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Co Diagnostics is operating at the current time. Most of Co Diagnostics' value examination focuses on studying past and present price action to predict the probability of Co Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Co Diagnostics' price. Additionally, you may evaluate how the addition of Co Diagnostics to your portfolios can decrease your overall portfolio volatility.